Pharmacology · Glossary
Receptor desensitization
Also written: Receptor adaptation
Definition
Receptor desensitization is a cell reducing its response after repeated stimulation, so the same signal produces less effect.
receptor desensitization is a receptor going quiet after repeated or constant stimulation: the cell turns down its own volume, so the same dose produces less effect. The cell may uncouple the receptor from its signaling machinery, pull the receptor inside, or make fewer receptors. This can contribute to tolerance, but the two terms are not interchangeable.
What does receptor desensitization mean?
Receptor desensitization means the cell has reduced its response without necessarily removing the receptor for good. A receptor can stop coupling efficiently to its usual signaling proteins within minutes. The cell can then internalize it—pull it away from the surface—or eventually make fewer copies. That slower loss is receptor downregulation, one possible mechanism rather than a synonym for every fading effect.
The practical desensitization meaning is simple: the message still arrives, but the cell has turned down the receiver. Some receptors recycle back to the surface and respond again. Others are degraded. Timing, receptor type, and the exact stimulus decide which version applies.
What does hexarelin show about GHS-R desensitization?
Hexarelin shows two different evidence tiers that should not be blended. In cultured cells, sustained ghrelin exposure made the growth hormone secretagogue receptor (GHS-R1a) respond less, move inside the cell, and recycle slowly (PMID 14576181). That is direct mechanistic evidence, but it is not a human trial of hexarelin.
In 12 healthy older adults, twice-daily hexarelin produced a progressively smaller growth-hormone response over 16 weeks. Four weeks after treatment stopped, the response returned near baseline (PMID 10990150). That supports partial, reversible GHS-R desensitization as an explanation for hexarelin’s fading effect. The study measured a hormone response—not muscle gain, recovery, or an ideal cycling schedule.
Why do peptides stop working?
Peptides can seem to stop working because of receptor adaptation, hormone feedback, a changed baseline, product variability, or an effect that was never measured reliably. Tolerance describes the smaller response; receptor desensitization proposes a cellular cause. A fading feeling alone cannot identify the mechanism.
CJC-1295 is a useful brake on the simple “constant stimulation always shuts receptors down” story. In healthy men, a long-acting dose raised basal growth-hormone output while preserving pulse frequency and size one week later (PMID 17018654). Pulsatile release may matter biologically, but that study did not test a cycling protocol. The honest grade is human biomarker evidence for hexarelin’s fading response, cell evidence for one receptor mechanism, and mechanistic reasoning—not human outcome data—for broader claims about why peptides stop working. See the evidence-grading guide for how those rungs differ.